Is DIACOMIT a Specialty Drug? Understanding its Classification
•
3 min read
According to the manufacturer, Biocodex, DIACOMIT (stiripentol) is an orphan medicinal product and is distributed exclusively through a specialty pharmacy, confirming it is a specialty drug. This classification significantly impacts how the medication is accessed and managed for patients with Dravet syndrome.